NEWS

Doudna and Charpentier Get Second CRISPR Patent in Europe – Labiotech.eu (blog)

2018-03-01 Michael Zand NEWS

Global Synthetic Biology Market Size Worth US $ 37.21 Billion | 2023 – The Chief Observer

Global Synthetic Biology Market Size Worth US $ 37.21 Billion | 2023The Chief ObserverA freshly introduced market research report, “Global Synthetic Biology Market” is expected to outstrip US $ 37.21 Billion over the forecast period from 2018 to 2023 h… Continue reading

2018-03-01 Michael Zand NEWS

Structure of a stem cell niche – Phys.Org

Structure of a stem cell nichePhys.OrgXiaoxi Wang, Ph.D., and Andrea Page-McCaw, Ph.D., are studying fruit fly ovaries, a model stem cell niche. They report in the February issue of Development that support cells called anterior escort cells, located n… Continue reading

2018-03-01 Michael Zand NEWS

How to Get the Most Out of Mesothelioma Immunotherapy – Asbestos.com (blog)

Asbestos.com (blog)How to Get the Most Out of Mesothelioma ImmunotherapyAsbestos.com (blog)Some ongoing clinical trials suggest immunotherapy may be more effective for treating mesothelioma than standard chemotherapy treatment. For immunotherapy to wor… Continue reading

2018-03-01 Michael Zand NEWS

How to Get the Most Out of Mesothelioma Immunotherapy – Asbestos.com (blog)

2018-03-01 Michael Zand NEWS

Vaxil Granted First US Patent for Its Cancer Immunotherapy Antibody Platform – Marketwired (press release)

Vaxil Granted First US Patent for Its Cancer Immunotherapy Antibody PlatformMarketwired (press release)NESS-ZIONA, ISRAEL–(Marketwired – March 01, 2018) – VAXIL BIO LTD. (TSX VENTURE: VXL), an innovative Israeli cancer research company focused on immu… Continue reading

2018-03-01 Michael Zand NEWS

NetworkNewsWire Announces Publication on Exciting Treatment Advancements Through Gene Therapy – GlobeNewswire (press release)

GlobeNewswire (press release)NetworkNewsWire Announces Publication on Exciting Treatment Advancements Through Gene TherapyGlobeNewswire (press release)PreveCeutical Medical Inc. is a health sciences company that develops innovative preventive therapies… Continue reading

2018-03-01 Michael Zand NEWS

Immune Cells Hunt Down Deadly Brain Tumors Thanks to Novel Target Molecule – Technology Networks

Technology NetworksImmune Cells Hunt Down Deadly Brain Tumors Thanks to Novel Target MoleculeTechnology NetworksScientists have successfully genetically engineered immune cells to hunt down and target brain tumors, thanks to the discovery of a novel mo… Continue reading

2018-03-01 Michael Zand NEWS

1
…
460
461
462
463
464
…
3,595

Labiotech.eu (blog)

Doudna and Charpentier Get Second CRISPR Patent in Europe
Labiotech.eu (blog)
Just a month after the European Patent Office revoked a CRISPR patent from Doudna and Charpentier’s competitors, they’ve been granted a second patent that covers a new form of the popular gene editing tool. The European Patent Office has granted CRISPR …

Login

Cart

Doudna and Charpentier Get Second CRISPR Patent in Europe – Labiotech.eu (blog)

Global Synthetic Biology Market Size Worth US $ 37.21 Billion | 2023 – The Chief Observer

Structure of a stem cell niche – Phys.Org

How to Get the Most Out of Mesothelioma Immunotherapy – Asbestos.com (blog)

How to Get the Most Out of Mesothelioma Immunotherapy – Asbestos.com (blog)

Vaxil Granted First US Patent for Its Cancer Immunotherapy Antibody Platform – Marketwired (press release)

NetworkNewsWire Announces Publication on Exciting Treatment Advancements Through Gene Therapy – GlobeNewswire (press release)

Immune Cells Hunt Down Deadly Brain Tumors Thanks to Novel Target Molecule – Technology Networks

Recent Posts

Blog Categories

Blog Categories

Blog Categories

Blog Categories

Blog Categories